Laurent M. Humeau

Laurent M. Humeau

Ph.D. Chief Scientific OfficeratInovio Pharmaceuticals· In proxies 2022–2023

Pay in FY2023-27% from the year before · Inovio Pharmaceuticals stock -67.3% the same year

Laurent M. Humeau was paid $1.1M in FY2023 (Dec), down 27%. Inovio Pharmaceuticals stock fell 67.3% that year.

Pay$100 in the stock at the end of FY21 → $10
Pay is from the Summary Compensation Table of each Inovio Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Inovio PharmaceuticalsPublic company · 4 yr
    • Ph.D. Chief Scientific Officer2022 – Present · 4 yrStock in role -99%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?